Pretreatment Amide Proton Transfer‐Weighted Imaging Histogram Analysis Combined With ER‐Negative and HER2‐Positive Expression Predicts Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer. Here, ERBB2 is linked to breast carcinoma.